We are Engineers. We Are Scientists. We are Drug Hunters.

Sona is an accomplished and innovative technology leader. She has excelled as a technology executive and a product and industry strategist for over 20 years. She led technology innovation for key product and consulting companies like Xenolytix, IBM, Dassault Systèmes, and UBS.

Sona has evangelized products with clear points of differentiation in Life-Sciences and FinTech. She has built and scaled up AI, Big Data Analytics, and IoT products from the ground up. Sona has led global cross-functional teams to gain market share.

Sona has a Master’s degree in Computer Science from New York Institute Of Technology and has attended Executive Marketing Management courses at Massachusetts Institute of Technology-Sloan School Of Management.

Philippe is an accomplished commercial and growth strategist with more than 20 years of experience driving revenue, partnerships, and market expansion for global technology and life-science organizations. He brings a strong track record of scaling businesses, developing high-impact go-to-market strategies, and forging strategic alliances across healthcare, biotech, and enterprise markets.

Philippe has led growth initiatives for both emerging ventures and established companies, shaping differentiated value propositions and guiding products from early market entry to broad commercial adoption. He has built and led global cross-functional teams across sales, marketing, business development, and customer success - consistently accelerating pipeline, expanding strategic accounts, and strengthening brand presence in competitive sectors.



He holds an advanced degree in business and has completed executive coursework in leadership and market strategy at a leading business school.

Kelvin is an accomplished and forward-thinking technology leader with more than 20 years of experience in AI, machine learning, and product strategy. He has driven AI and data strategy across leading product, healthcare, and consulting organizations, focusing on high-impact solutions for life-sciences, diagnostics, and clinical decision support.

Kelvin has a strong record of evangelizing products with clear differentiation in Biotech and HealthTech. He has built and scaled AI platforms, machine-learning pipelines, and Big Data analytics solutions from the ground up - operationalizing models for real-world use, meeting regulatory and privacy requirements, and establishing partnerships across R&D and commercial teams.

He holds an advanced degree in computer science and has completed executive coursework in product strategy and management at a top business school. Kelvin combines deep technical fluency with commercial and regulatory savvy, positioning NeuroBio to turn cutting-edge AI into safer, faster, and more effective solutions for patients and clinicians.